MedPath

Pentagastrin

Pentagastrin

Approved
Approval ID

abc92ef1-f9c3-4eac-a273-9b8705b36c29

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 19, 2012

Manufacturers
FDA

AnazaoHealth Corporation

DUNS: 011038762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pentagastrin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51808-207
Product Classification
G
Generic Name
Pentagastrin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 8, 2012
FDA Product Classification

INGREDIENTS (3)

PENTAGASTRINActive
Quantity: 250 ug in 1.6 mL
Code: EF0NX91490
Classification: ACTIB
PROPYLPARABENInactive
Quantity: 0.2 mg in 1.6 mL
Code: Z8IX2SC1OH
Classification: IACT
METHYLPARABENInactive
Quantity: 1.8 mg in 1.6 mL
Code: A2I8C7HI9T
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pentagastrin - FDA Drug Approval Details